Myson Century, Inc. is an integrated circuit design company founded in 1991 that specializes in MCU platforms combined with video and communication technologies. The company designs mobile communication chips, embedded system IC modules, automotive chip modules, and video surveillance chips. In 2024, it expanded into the development of unmanned aerial vehicles (UAVs), including small multi-rotor drones, medium multi-axis drones, and vertical take-off and landing (VTOL) long-range payload drones for inspection, disaster relief, logistics, and aerial monitoring. The group also operates in the biotechnology and health sector through its subsidiary Chaohe Biotech, which produces health supplements and exosome-based products such as Eob686 and Weigu Mi. Myson Century integrates AI technology into its health services, offering an online nutritionist service powered by large language models to provide personalized health advice. The company supports multiple satellite positioning systems with anti-jamming technology for its drone products.
More
Summarised from the company's own disclosures, fiscal year ended Oct 2026
Industry
Semiconductors
Homepage
myson.com.tw
Sector
Technology
IR page
myson.com.tw/investor
Tags
ic design, mcu, unmanned aerial vehicles, biotechnology, health supplements, exosomes, embedded systems, automotive chips, video surveillance, ai health services, Chaohe Biotech, Eob686, Weigu Mi, AI Online Nutritionist
More
Press page
—
Metrics
Market cap
NT$ 23.475B
Market cap (USD)
$ 712.496M
P/E
6.35
PEG
—
P/BV
12.91
P/S
4.25
P/OCF
69.09
P/FCF
—
Dividend yield
—
Turnover / mcap
—
ROE
141.9%
ROI
88.1%
ROIC
54.1%
Profit margin
54.7%
Revenue growing
Yes
Profits growing
Yes
Revenue up 3y
Yes
Revenue up 5y
No
Earnings growth 3y (net profit CAGR)
—
Profitable
Yes
Margin expanding
No
Buying back stock
No
Diluting (TTM)
—
Debt/Equity
—
Podcast bulls (TTM)
Sign up
Podcast bears (TTM)
Sign up
Podcast sentiment (TTM)
Sign up
Podcast sentiment % (TTM)
Sign up
News sentiment (TTM)
0
Quality score
33.3%
Buys, 1w
Sign up
Buys, 1m
Sign up
Buys, 1y
Sign up
Sells, 1w
Sign up
Sells, 1m
Sign up
Sells, 1y
Sign up
Sign up to see this company's insider trades
Fundamentals
(all numbers in TWD)
Compare
All 29 figures
Annual
Quarterly
Compare with
×
Revenue
2.974B
628.23M
85.353M
18.432M
13.989M
19.789M
51.919M
86.98M
175.104M
169.822M
169.156M
211.304M
161.167M
203.937M
198.732M
231.205M
Net profit
1.626B
268.291M
31.05M
-2.671M
-30.008M
-30.318M
-24.182M
12.934M
-7.634M
-99.821M
-64.097M
-59.609M
-79.045M
-35.227M
75.511M
129.259M
Share price
98.1
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
P/S
9.63
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
Sign up to see institutional holdings
Sign Up
Podcast Mentions
Sign up to see podcast mentions and sentiment
Sign Up
Material information published on MOPS, newest first, subjects as filed in Chinese, guarantee and loan balance notices and routine equipment purchases included. The link opens the company's material information on MOPS.
AI comment
The company's subsidiary is leasing a warehouse from a related party for approximately TWD 7.8 million in total rights value (TWD 226,000 per month) for a three-year term. This is a routine operational expense and a minor related-party transaction that does not materially impact the company's valuation or financial health.
AI comment
The company announced the lending of a total of TWD 80 million to its subsidiaries for short-term liquidity needs. This is a routine internal capital allocation matter involving a small fraction of the parent's equity (4.4% of net asset value) and does not impact the parent company's value or risk profile significantly.
AI comment
This is a routine regulatory filing announcing that the board has approved the third-quarter consolidated financial report. It does not contain new substantive information or analysis that would alter the company's valuation beyond the reported figures themselves.
AI comment
The company's subsidiary acquired the operating rights of Han Yu Technology for TWD 150 million using operating funds. This is a routine corporate acquisition filing with no disclosed strategic impact or financial magnitude relative to the parent company's size, providing no new information on value creation.
AI comment
The company's subsidiary won a bid for a framework agreement to supply training drones to the Taiwan Bank Procurement Department, with an estimated value of TWD 132 million. However, the text explicitly states this is a 'common supply contract' where actual orders depend on government agencies' needs, meaning the revenue is not guaranteed. Given the company's FY2025 revenue of TWD 2.974 billion, this potential upside is minor and speculative.
AI comment
This is a routine filing confirming the completion of the registered capital reduction and the resulting minor change in share count and net asset value per share. It is a formal procedural step with no new financial or strategic implications for company value.
AI comment
This is a routine filing confirming the completion of a treasury share cancellation and the resulting change in registered capital. The reduction in share count is negligible (less than 1%), and the filing itself provides no new information regarding the company's operational performance or future prospects.
AI comment
This is a routine filing updating the internal regulations for restricted stock units (RSUs) granted to employees. It involves no new financial commitments, capital raising, or operational changes, and the company states there is no impact on its financials.
AI comment
This is a routine regulatory filing disclosing monthly and quarterly financial self-assessment figures to comply with market rules regarding trading information standards; it does not constitute new operational news or a formal earnings release that would independently drive valuation changes.
AI comment
This is a routine administrative filing correcting minor page references and content in the already-published 2025 Annual Report to comply with regulatory requests. It does not convey any new financial or operational information relevant to valuation.
AI comment
This is a routine administrative notice setting the ex-dividend date and adjusting the per-share cash dividend amount due to a prior capital increase. It confirms a previously announced dividend distribution and contains no new information regarding company value or performance.
AI comment
This is a routine regulatory filing disclosing monthly, quarterly, and trailing twelve-month financial results. While revenue growth is strong, net profit declined significantly year-over-year. Routine financial disclosures are scored 0 as they do not represent new strategic developments or surprises beyond the reported figures.
AI comment
This is a routine filing confirming the cancellation of treasury shares and capital reduction. The reduction is minor (0.86% of share capital) and represents the formal completion of a previously announced buyback, which is a neutral administrative event.
AI comment
This is a routine filing announcing that the board has approved the Q2 consolidated financial report. While the text provides cumulative figures for the first half of the year (revenue ~2.88B TWD, net income ~250.8M TWD), it does not provide the specific Q2 standalone figures or a comparison to the prior year's Q2 to allow for a direct assessment of quarterly momentum or profit change percentage as required for scoring results. Without the ability to calculate the specific profit change against
AI comment
This is a routine notice announcing the date of the board meeting to review the Q2 financial results. The announcement of the meeting date itself conveys no new information about the company's value or performance.
AI comment
The company announced a routine internal loan of TWD 5,000 thousand to its subsidiary for short-term funding needs. This is a minor capital allocation formality with no material impact on shareholder value.
AI comment
This is a routine administrative notice regarding the adjustment of the stock dividend distribution ratio due to the company's repurchase of 2.5 million shares. It confirms the ex-rights date and record date for a previously approved capital increase, which is a formal procedural step with no new value implications.
AI comment
This is a routine filing of the resolutions from the Annual General Meeting, including the approval of the annual financial statements, articles of association, and standard capital increases. These are formalities that convey no new information about the company's value or performance.
AI comment
The company announces a cooperation agreement with its subsidiary to streamline group governance and management efficiency by supporting the subsidiary in taking control of a healthcare subsidiary. This is an internal organizational restructuring with no stated financial value or binding commercial terms, representing a minor operational improvement.
AI comment
This is a routine filing announcing the expiration of a public tender offer period for a third-party target (Tianliang Biotech) in which Myson Century participated. The deal was already announced; this is merely a procedural confirmation of completion with no new financial impact or strategic revelation for Myson Century itself.
Show all 20 news items
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat.
Shared by
Asian Century Stocks and
Uncovered Thai Stocks .
Thank you.
Base
Enforce Recency
Overview
Bull Bear
Competitive Advantages
Supply Chain
Segments
Earnings Results
Earnings Calls
Management
Stock Price Analysis
Comps
Forward Projection
Red Flags
Management Questions
Devils Advocate
Constraints
Share Value Compliance
Equity Research
Myson Century, Inc. (ticker 5314.TWO), listed in Taiwan.
Copy
Clear
Copied
ETFs Holding Myson Century, Inc.
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
AVSE
0.06%
166,280
$ 117.244K
Nov 16, 2026
AVEE
0.03%
56,727
$ 39.998K
Nov 16, 2026
AVEM
0.01%
2,993,059
$ 2.11M
Nov 16, 2026